Feasibility Randomized Controlled Trial Using a 'Leapfrog' Design
- Conditions
- DepressionAnhedonia
- Interventions
- Behavioral: Imagery cognitive bias modification
- Registration Number
- NCT04791137
- Lead Sponsor
- Ruhr University of Bochum
- Brief Summary
This study is a small-scale randomized controlled trial (RCT) using a 'Leapfrog' design (Blackwell, Woud, Margraf, \& Schönbrodt, 2019) with the aim of investigating feasibility of this design in the context of an RCT of an internet-delivered intervention. The leapfrog design will be applied to a simple cognitive training intervention, imagery cognitive bias modification (imagery CBM), completed over a four-week training period. The trial will start with the three arms described in the initial registration, but these will be removed and new arms added over the course of the trial on the basis of sequential Bayesian analyses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 188
- Aged 18 or over
- Fluent German
- Willing and able to complete all study procedures (including having a suitable device/ internet access)
- Interested in monitoring their mood over the study time-period (one month)
- Score of ≥ 6 on the Quick Inventory of Depressive Symptomatology, including ≥ 1 on item 13 (General Interest), indicating at least mild levels of depression symptoms and anhedonia
- No exclusion criteria set
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Standard imagery cognitive bias modification with frequent brief sessions Imagery cognitive bias modification Participants are scheduled to complete a first introductory session then 40 brief (\~5 min) sessions of a 'standard' imagery cognitive bias modification (CBM) intervention, with 2 per day five days per week for each of the four training weeks. In addition, as with the arm "Standard imagery cognitive bias modification plus additional rationale and transfer instructions", participants are first presented with a more extended rationale for completing the training, and during many of the training sessions are provided with instructions to practice retrieval and rehearsal of the training contents in between sessions. This arm was added into the ongoing trial on 30.05.21. Standard imagery cognitive bias modification plus additional rationale and transfer instructions Imagery cognitive bias modification Participants are scheduled to complete a first introductory session then 12 further training sessions of a 'standard' imagery cognitive bias modification (CBM) intervention, but in addition are first presented with a more extended rationale for completing the training, and during each training session are provided with instructions to practice retrieval and rehearsal of the training contents in between sessions. Standard imagery cognitive bias modification with a less intensive schedule Imagery cognitive bias modification Participants are scheduled to complete a first introductory session then 11 further sessions of a 'standard' imagery cognitive bias modification (CBM) intervention, with 3 sessions scheduled for each of the four training weeks. Sessions have fewer training scenarios than the "Standard imagery cognitive bias modification" condition and more varied task instructions. In addition, as with the arm "Standard imagery cognitive bias modification plus additional rationale and transfer instructions", participants are first presented with a more extended rationale for completing the training, and during many of the training sessions are provided with instructions to practice retrieval and rehearsal of the training contents in between sessions. This arm was added into the ongoing trial on 09.06.21. Standard imagery cognitive bias modification Imagery cognitive bias modification Participants are scheduled to complete a first introductory session then 12 further training sessions of a 'standard' imagery cognitive bias modification (CBM) intervention derived from that implemented in previous studies.
- Primary Outcome Measures
Name Time Method Dimensional Anhedonia Rating Scale (DARS) Post-intervention (4 weeks post-baseline). A 17-item scale measuring anhedonia (Rizvi et al., 2015). The primary analysis is a between-groups comparison of post-intervention scores, controlling for baseline scores, using constrained longitudinal data analysis (cLDA). An approximate Bayes factor is then calculated via the t-statistic for the Time x Group effect with a directional default Cauchy prior (rscale parameter = √2/2).
- Secondary Outcome Measures
Name Time Method GAD-7 Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline) A brief 7-item measure of generalized anxiety symptoms (Spitzer et al., 2006)
Quick Inventory of Depressive Symptomatology - Self Report (QIDS) Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline) A 15-item version of the QIDS (Rush et al., 2013), excluding the suicidal ideation item, will be used
Positive Mental Health Scale (PMH) Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline) A 9-item questionnaire designed to assess positive mental health (Lukat et al., 2016)
Prospective Imagery Test (PIT) Baseline and post-intervention (4 weeks post-baseline) A measure designed to assess vividness of positive and negative future-oriented imagery (Stöber et al., 2000), here administered with as two 10-item parallel versions (each with 5 positive and 5 negative items).
Ambiguous Scenarios Test for Depression (AST) Baseline and post-intervention (4 weeks post-baseline) A measure with two 15-item parallel forms designed to assess depression-relevant negative interpretation biases (Rochbacher \& Reinecke, 2014)
Negative Effects Questionnaire - Short Form (NEQ) Post-intervention (4 weeks post-baseline) A 20-item questionnaire designed to assess potential negative effects of psychological interventions (Rozental et al., 2019)
Trial Locations
- Locations (1)
Ruhr University of Bochum
🇩🇪Bochum, Nordrhein-Westfalen, Germany